Breakthrough Treatment for Hepatitis C Shows 100% Success
May 4, 2016
Hepatitis C: elbasvir/grazoprevir combo tops popular treatment
May 5, 2016
Show all

Study Shows Potential of Novel Compound to Treat Multiple Sclerosis

A new medication is being studied for its potential to repair damaged myelin sheaths and restore function to patients with secondary-progressive multiple sclerosis.

For the treatment of secondary-progressive multiple sclerosis (SPMS), NDC-1308−a small molecule that activates intracellular pathways for oligodendrocyte progenitor cell (OPC) differentiation−showed favorable pharmacokinetic properties and was safe in a mice study.

“NDC-1308 possesses many desirable qualities for a therapeutic to treat [multiple sclerosis (MS)],” said study researcher Steven H. Nye, PhD, who is vice-president of discovery at ENDECE (Mequon, Wisconsin). “In particular, it … readily traverses the blood-brain barrier where it can induce OPCs in the [central nervous system (CNS)] to differentiate into cells that synthesize and maintain the myelin sheath, in a similar manner thought to occur in healthy individuals.”

Read Full Article: Study Shows Potential of Novel Compound to Treat Multiple Sclerosis

 

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.